CA
TXMD icon

Commerzbank Aktiengesellschaft’s TherapeuticsMD TXMD Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,083
Closed -$312K – 986
2016
Q4 		$312K Buy
+1,083
New +$336K ﹤0.01% 768

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Commerzbank Aktiengesellschaft's TXMD Position: Q1 2017 in Review

Commerzbank Aktiengesellschaft sold out of TherapeuticsMD (TXMD) in Q1 2017, closing a stake of 1,083 shares — an estimated $312K sold.

Commerzbank Aktiengesellschaft first reported a position in TXMD in Q4 2016 and held it in 1 quarter. The position peaked at $312K in Q4 2016. 138 funds tracked by Wall St. Rank hold TXMD as of Q1 2017.

  • Commerzbank Aktiengesellschaft reported no remaining TherapeuticsMD position as of Q1 2017 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 1,083 TherapeuticsMD shares in Q1 2017, an estimated $312K.
  • Commerzbank Aktiengesellschaft first reported a position in TherapeuticsMD in Q4 2016 and held it in 1 quarter.
  • Commerzbank Aktiengesellschaft's TherapeuticsMD position peaked at $312K in Q4 2016.
  • 138 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.